Cancer Research AACR Membership  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 2817-2824, July 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldridge, D. R.
Right arrow Articles by Radford, I. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aldridge, D. R.
Right arrow Articles by Radford, I. R.

Explaining Differences in Sensitivity to Killing by Ionizing Radiation between Human Lymphoid Cell Lines

David R. Aldridge and Ian R. Radford1

Sir Donald and Lady Trescowthick Research Laboratories, Peter MacCallum Cancer Institute, St. Andrews Place, East Melbourne, Victoria 3002, Australia

We surveyed five human hematopoietic cell lines (HSB-2, MOLT-4, Reh, CEM, and HL-60) to determine whether any simple correlates with sensitivity to killing by {gamma}-irradiation might be revealed. The clonogenic survival {gamma}-ray dose-response curves for these cell lines cover a wide range of sensitivities. Consistent with previous results for murine hematopoietic cell lines, there was a clear correlation between the rapidity with which irradiation induced apoptosis and clonogenic radiosensitivity of a cell line, although the relationship between timing of apoptosis and radiosensitivity differed between human and murine cell lines. Flow cytometric determination of cell cycle distribution after irradiation showed that differences between human hematopoietic cell lines, in the rate of induction of apoptosis, were generally related to the functioning of cell cycle checkpoints. Whereas the rapidly dying and radiosensitive HSB-2 cell line underwent apoptosis from different points in the cell cycle, the more slowly dying cell lines showed a variety of cell cycle arrest profiles and initiated apoptosis after accumulation of cells in the G2 phase. The lag-phase between arrest in G2 and induction of apoptosis was comparable for MOLT-4, Reh, and CEM; however, HL-60 cells showed a markedly longer G2 arrest that correlated with their greater radioresistance. The results suggest that the total length of time available for DNA damage repair (irrespective of whether this time accrues as blockage in G1, S, or G2), prior to potential activation of apoptosis, is a critical determinant of radiosensitivity in human hematopoietic cell lines. Comparison of the p53 status of these cell lines suggested that mutations in the TP53 gene are contributing to the delay of induction of apoptosis seen in the more radioresistant cell lines. The sensitivity of MOLT-4 and HL-60 cells to killing by DNA-associated 125I decays was determined and was found to correlate with the relative sensitivity of these lines to {gamma}-irradiation. The highly localized deposition of energy by 125I decays argues that DNA damage is a potent initiator of apoptosis in these cell lines. The results presented suggest that differences in the radiosensitivity of the cell lines examined reflect differences in the rapidity of induction of apoptosis and that radiation-induced cell death in hematopoietic cells can be explained as a response to DNA damage.

1 To whom requests for reprints should be addressed, at Research Division, Peter MacCallum Cancer Institute, Locked Bag No. 1, A'Beckett Street, Melbourne, Victoria 8006, Australia. Phone: 61-3-9656-1291; Fax: 61-3-9656-1411; E-mail: i.radford@pmci.unimelb.edu.au.

Received 12/ 9/97. Accepted 4/23/98.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Iwasa, I. Okamoto, M. Suzuki, T. Nakahara, K. Yamanaka, E. Hatashita, Y. Yamada, M. Fukuoka, K. Ono, and K. Nakagawa
Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines
Clin. Cancer Res., October 15, 2008; 14(20): 6496 - 6504.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-K. Tai, J. I. Lee, K. K. Ang, A. K. El-Naggar, K. A. Hassan, D. Liu, J. J. Lee, H. Ren, W. K. Hong, and L. Mao
Loss of Fhit Expression in Head and Neck Squamous Cell Carcinoma and Its Potential Clinical Implication
Clin. Cancer Res., August 15, 2004; 10(16): 5554 - 5557.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Scott, J. D. Earle, and P. H. Gumerlock
Functional p53 Increases Prostate Cancer Cell Survival After Exposure to Fractionated Doses of Ionizing Radiation
Cancer Res., November 1, 2003; 63(21): 7190 - 7196.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
O. S. Frankfurt and A. Krishan
Microplate Screening for Apoptosis with Antibody to Single-Stranded DNA Distinguishes Anticancer Drugs from Toxic Chemicals
J Biomol Screen, April 1, 2003; 8(2): 185 - 190.
[Abstract] [PDF]


Home page
Mol Cancer ResHome page
Y. Takada, M. Hachiya, S.-H. Park, Y. Osawa, T. Ozawa, and M. Akashi
Role of Reactive Oxygen Species in Cells Overexpressing Manganese Superoxide Dismutase: Mechanism for Induction of Radioresistance
Mol. Cancer Res., December 1, 2002; 1(2): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-C. Hsu, L. D. Shultz, X. Su, J. Shi, P.-A. Yang, M. J. Relyea, H.-G. Zhang, and J. D. Mountz
Mutation of the Hematopoietic Cell Phosphatase (Hcph) Gene Is Associated with Resistance to {{gamma}}-Irradiation-Induced Apoptosis in Src Homology Protein Tyrosine Phosphatase (SHP)-1-Deficient ""Motheaten"" Mutant Mice
J. Immunol., January 15, 2001; 166(2): 772 - 780.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. Sleiman and B. W. Stewart
Early Caspase Activation in Leukemic Cells Subject to Etoposide-induced G2-M Arrest: Evidence of Commitment to Apoptosis Rather Than Mitotic Cell Death
Clin. Cancer Res., September 1, 2000; 6(9): 3756 - 3765.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
X. Wang, C. H. McGowan, M. Zhao, L. He, J. S. Downey, C. Fearns, Y. Wang, S. Huang, and J. Han
Involvement of the MKK6-p38gamma Cascade in gamma -Radiation-Induced Cell Cycle Arrest
Mol. Cell. Biol., July 1, 2000; 20(13): 4543 - 4552.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
J. R. Jackson, A. Gilmartin, C. Imburgia, J. D. Winkler, L. A. Marshall, and A. Roshak
An Indolocarbazole Inhibitor of Human Checkpoint Kinase (Chk1) Abrogates Cell Cycle Arrest Caused by DNA Damage
Cancer Res., February 1, 2000; 60(3): 566 - 572.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Ashush, L. A. Rozenszajn, M. Blass, M. Barda-Saad, D. Azimov, J. Radnay, D. Zipori, and U. Rosenschein
Apoptosis Induction of Human Myeloid Leukemic Cells by Ultrasound Exposure
Cancer Res., February 1, 2000; 60(4): 1014 - 1020.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
J. M. Brown and B. G. Wouters
Apoptosis, p53, and Tumor Cell Sensitivity to Anticancer Agents
Cancer Res., April 1, 1999; 59(7): 1391 - 1399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Lemasson and J. K. Nyborg
Human T-cell Leukemia Virus Type I Tax Repression of p73beta Is Mediated through Competition for the C/H1 Domain of CBP
J. Biol. Chem., May 4, 2001; 276(19): 15720 - 15727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.